Abstract |
Oestrogen and progesterone receptor assays were performed in 286 women with primary breast cancer, and the patient group was followed up for a minimum of 24 months. Of the 263 patients belonging to clinical stages I-III and serving as the population used for calculation of disease-free interval only 1.9% received postoperative endocrine treatment and 6.5% chemotherapy. No significant relationship between the presence or concentrations of oestrogen or progesterone receptor and the disease-free interval was observed. It is therefore possible that the positive relationship between these variables reported in some investigations reflects an influence by adjuvant endocrine measures.
|
Authors | A Alanko, E Heinonen, T M Scheinin, E M Tolppanen, R Vihko |
Journal | British journal of cancer
(Br J Cancer)
Vol. 50
Issue 5
Pg. 667-72
(Nov 1984)
ISSN: 0007-0920 [Print] England |
PMID | 6498064
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Receptors, Estrogen
- Receptors, Progesterone
|
Topics |
- Breast Neoplasms
(analysis, pathology, surgery)
- Female
- Follow-Up Studies
- Humans
- Mastectomy
- Neoplasm Metastasis
- Neoplasm Staging
- Prognosis
- Receptors, Estrogen
(analysis)
- Receptors, Progesterone
(analysis)
- Time Factors
|